Jailani, Jelpin J.
HRN: 27-03-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/25/2025
05/02/2025
IV
600mg
Every 6hrs
Open Fracture, Tibia, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes